UPDATE: Goldman Sachs Raises PT on Brookdale Senior Living to $30

Goldman Sachs is out with its report today on Brookdale Senior Living BKD, raising its PT from $28 to $30. In a note to clients, Goldman Sachs writes, "Incremental positives for senior housing operator Brookdale Senior Living: (1) Timing – BKD has recently sold off 15% based on a potential Medicare / Medicaid cut for skilled nursing reimbursement. We see an attractive entry point as just 7% of BKD's revenues are exposed to these payments; and (2) Rent growth - we raise our CFFO estimates modestly on stronger-than expected rents in the early part of a multi-year up-cycle. Separately, we highlight that our favorable view for senior housing fundamentals remains unchanged. Limited supply growth and strong demographics auger well for BKD. Buy BKD for 21% upside to our new 12-month price target of $30." Shares of BKD closed Wednesday at $24.83, up 2.22% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsBrookdale Senior LivingGoldman SachsHealth CareHealth Care Facilities
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!